Item Type | Name |
Concept
|
Vascular Endothelial Growth Factor A
|
Concept
|
Platelet-Derived Growth Factor
|
Concept
|
STAT3 Transcription Factor
|
Concept
|
GA-Binding Protein Transcription Factor
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Connective Tissue Growth Factor
|
Concept
|
Transcription Factor AP-1
|
Concept
|
NF-E2-Related Factor 2
|
Concept
|
STAT1 Transcription Factor
|
Concept
|
Receptors, Mating Factor
|
Academic Article
|
Up-regulation of p27(kip1) contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy.
|
Academic Article
|
Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury.
|
Academic Article
|
Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
|
Academic Article
|
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression.
|
Academic Article
|
Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway.
|
Academic Article
|
Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
|
Academic Article
|
Nitroalkenes suppress lipopolysaccharide-induced signal transducer and activator of transcription signaling in macrophages: a critical role of mitogen-activated protein kinase phosphatase 1.
|
Academic Article
|
Targeting the Nrf2 pathway against cardiovascular disease.
|
Academic Article
|
Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.
|
Academic Article
|
An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy.
|
Academic Article
|
Ubiquitin carboxyl terminal hydrolase L1 negatively regulates TNFalpha-mediated vascular smooth muscle cell proliferation via suppressing ERK activation.
|
Academic Article
|
Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.
|
Academic Article
|
An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes.
|
Academic Article
|
Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo.
|
Academic Article
|
A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
|
Academic Article
|
Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2.
|
Academic Article
|
American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathway.
|
Academic Article
|
Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-?B.
|
Academic Article
|
Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
|
Academic Article
|
Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2.
|
Academic Article
|
Ubiquitin carboxyl terminal hydrolyase L1-suppressed autophagic degradation of p21WAF1/Cip1 as a novel feedback mechanism in the control of cardiac fibroblast proliferation.
|
Academic Article
|
Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.
|
Academic Article
|
Targeting Nrf2 by dihydro-CDDO-trifluoroethyl amide enhances autophagic clearance and viability of ?-cells in a setting of oxidative stress.
|
Academic Article
|
Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
|
Academic Article
|
High level expression, efficient purification, and bioactivity of recombinant human metallothionein 3 (rhMT3) from methylotrophic yeast Pichia pastoris.
|
Academic Article
|
Identifying panaxynol, a natural activator of nuclear factor erythroid-2 related factor 2 (Nrf2) from American ginseng as a suppressor of inflamed macrophage-induced cardiomyocyte hypertrophy.
|
Academic Article
|
Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
|
Academic Article
|
Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.
|
Academic Article
|
Nuclear factor erythroid-2 related factor 2 (Nrf2)-mediated protein quality control in cardiomyocytes.
|
Academic Article
|
Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein.
|
Academic Article
|
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3?/Fyn pathway.
|
Academic Article
|
Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice.
|
Academic Article
|
Critical role of the endogenous renin-angiotensin system in maintaining self-renewal and regeneration potential of epidermal stem cells.
|
Academic Article
|
Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice.
|
Academic Article
|
Molecules from American Ginseng Suppress Colitis through Nuclear Factor Erythroid-2-Related Factor 2.
|
Academic Article
|
An inhibitor role of Nrf2 in the regulation of myocardial senescence and dysfunction after myocardial infarction.
|
Academic Article
|
The Spike Protein of SARS-CoV-2 Impairs Lipid Metabolism and Increases Susceptibility to Lipotoxicity: Implication for a Role of Nrf2.
|
Academic Article
|
Nrf2-Mediated Dichotomy in the Vascular System: Mechanistic and Therapeutic Perspective.
|